Routine Tumor Testing for Homologous Recombination Deficiency in Patients With High Grade Epithelial Ovarian Cancer at a Statewide Gynecological Cancer Service in Western Australia: An Observational Study
Compliance with HRD testing was high, and only three of 79 (3.8%) patients had non-diagnostic results.
Authors
- Benhur Amanuel
- Martin Buck (ORCID: https://orcid.org/0000-0002-7580-8982)
- G.C.W. Howard
- Paul A. Cohen (ORCID: https://orcid.org/0000-0002-4860-9232)
- Emma Allanson (ORCID: https://orcid.org/0000-0002-4786-4354)
- Cassandra Nichols (ORCID: https://orcid.org/0000-0003-2578-7076)
- Chloe Ayres
- Kaamini Planisamy
- Tarek Meniawy (ORCID: https://orcid.org/0000-0002-1457-6137)
- Yee Leung (ORCID: https://orcid.org/0000-0003-0349-8652)
- G. Raj K. A. Mohan
- Navin David Pallayoor
- Elena Ctori
Institutions
- The University of Western Australia (AU)
- King Edward Memorial Hospital (AU)
- Sir Charles Gairdner Hospital (AU)
Publication Details
- Journal
- Cancer Reports
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cnr2.70335
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Peter MacCallum Cancer Centre